• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIANG Feng, LI Duo, WANG Rongbin, SHU Chang, DING Li. Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2019, 50(1): 75-80. DOI: 10.11665/j.issn.1000-5048.20190110
Citation: LIANG Feng, LI Duo, WANG Rongbin, SHU Chang, DING Li. Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2019, 50(1): 75-80. DOI: 10.11665/j.issn.1000-5048.20190110

Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS

More Information
  • The aim of this study was to develop a highly sensitive and specific LC-MS/MS method to explore the pharmacokinetic properties and absolute bioavailability of isoschaftoside in rats. Blood sampling was performed at different time points after intragastric administration of isoschaftoside(1. 5, 3. 0, 6. 0 mg/kg)and 0. 5 mg/kg by intravenous injection. Isoschaftoside was analyzed by a validated LC-MS/MS method in plasma; the pharmacokinetic parameters and absolute bioavailability were evaluated by software DAS 3. 0. The results showed that the linear concentration ranges of isoschaftoside was 1. 0- 500. 0 ng/mL(r=0. 997 6). The precision, accuracy, matrix effect, sensitivity, dilution reliability and stability met the requirements of biological sample analysis. For ig administration of isoschaftoside(1. 5, 3. 0, 6. 0 mg/kg), the pharmacokinetic parameter cmax was(109. 34±22. 87), (259. 84±95. 35)and(499. 26±288. 09)ng/mL; AUC0-t was(310. 57±46. 18), (552. 67±207. 14)and(1 075. 03±371. 19)h ·ng/mL; t1/2 was(2. 36±0. 22), (2. 91±0. 19)and(3. 04±0. 86)h; tmax was(1. 03±0. 25), (1. 18±0. 17)and(1. 5±0. 43)h; MRT0-t was(11. 33±1. 53), (11. 27±1. 09)and(8. 29±0. 76)h, respectively. For iv administration of isoschaftoside(0. 5 mg/kg), the pharmacokinetic parameter AUC0-t was(1 536±421. 3)h ·ng/mL; t1/2 was(2. 57±0. 46)h; MRT0-t was(9. 55±2. 37)h. Furthermore, the absolute bioavailability was 6. 73%, 5. 99%, 5. 80%, respectively. The LC-MS/MS analysis method established in this study was accurate and sensitive, so it can be applied to the pharmacokinetic study of isoschaftoside.
  • [1]
    Zhang LL,Xu W,Xu YL,et al.Therapeutic potential of Rhizoma Alismatis:a review on ethnomedicinal application,phytochemistry,pharmacology,and toxicology[J].Ann NY Acad Sci,2017,1401(1):90-101.
    [2]
    Gao X, Sun C, Yu Z, et al. Correlation analysis between the chemical contents and bioactivity for the quality control of Alismatis Rhizoma[J].Acta Pharm Sin B,2018,8(2):242-251.
    [3]
    Chu Y,Jiang H,Ju J,et al.A metabolomic study using HPLC-TOF/MS coupled with ingenuity pathway analysis:intervention effects of Rhizoma Alismatis on spontaneous hypertensive rats[J].J Pharm Biomed Anal,2016,117:446-452
    [4]
    Shan DS,Ming ZH,Chun Qi B,et al.Nematocidal flavone-C-glycosides against the root-knot nematode(Meloidogyne incognita)from Arisaema erubescens tubers[J].Molecules,2011,16(6):5079-5086.
    [5]
    Dai Y,Tan A,Chen H,et al.Quantification of desoxyrhapontigenin(4-methoxyresveratrol)in rat plasma by LC-MS/MS:application to pre-clinical pharmacokinetic study[J].J Pharm Biomed Anal,2018,153:95-101.
    [6]
    Yang M,Dong Z,Jiang X,et al.Determination of S-allylmercaptocysteine in rat plasma by LC-MS/MS and its application to a pharmacokinetics study[J].J Chromatogr Sci,2018.doi: 10.1093/chromsci/bmy001.
    [7]
    Chen JT, Guo XM, Yang P, et al. Quantitative analysis of the cyclic peptide GG-8-6 in rat plasma using LC-MS/MS and its application to a pharmacokinetic study[J].J Pharm Biomed Anal,2018,159:217-223.
    [8]
    Cai J,Zhu L,Xu Y,et al.A UPLC-MS/MS method for determination of schaftoside in rat plasma and its application to phamacokinetic study[J].Lat Am J Pharm,2016,35(3):545-550.
  • Related Articles

    [1]JI Shunli, SONG Fanfan, ZHENG Yang, DING Li. Simultaneous determination of amoxicillin and clavulanic acid by LC-MS/MS in human plasma and its application to a bioequivalence study[J]. Journal of China Pharmaceutical University, 2019, 50(6): 699-706. DOI: 10.11665/j.issn.1000-5048.20190610
    [2]LI Jingjing, TAN Jingfu, YANG Jie, WANG Qiang. Pharmacokinetic study of corosolic acid in normal rats and diabetic rats by LC-MS[J]. Journal of China Pharmaceutical University, 2014, 45(1): 84-87. DOI: 10.11665/j.issn.1000-5048.20140115
    [3]MU Yanan, YANG Jin. Determination of epothilone B in human blood by LC-MS/MS and its application in phase I pharmacokinetics study[J]. Journal of China Pharmaceutical University, 2013, 44(1): 89-92. DOI: 10.11665/j.issn.1000-5048.20130115
    [4]SI Qian, CHEN Yuan-cheng, HUANG Li-hua, CHENG Yu, HE Hua, LIU Xiao-quan. Determination of nebivolol in human plasma by LC-MS/MS and study of its pharmacokinetics on the Chinese[J]. Journal of China Pharmaceutical University, 2011, 42(2): 136-140.
    [5]WU Fei, GAO Fang, DING Li, MAO Xiao-ming, MA Peng-cheng. Determination of zofenopril and its active metabolite zofenoprilat by a new derivative LC-MS method and their pharmacokinetics in healthy Chinese volunteers[J]. Journal of China Pharmaceutical University, 2009, 40(4): 353-358.
    [6]Determination of Ranolazine and Its Pharmacokinetics in Dog by LC-MS[J]. Journal of China Pharmaceutical University, 2004, (2): 59-62.
    [7]Determination of Clarithromycin in Human Plasma by LC-MS Method[J]. Journal of China Pharmaceutical University, 2004, (1): 52-55.
    [8]Study of Pharmacokinetics and Relative Bioavailability of Clarithromycin[J]. Journal of China Pharmaceutical University, 2003, (4): 23-26.
    [9]Determination of Descarboethoxyloratadine and Its Pharmaco-kinetics in Human Plasma by LC-MS[J]. Journal of China Pharmaceutical University, 2002, (4): 46-49.
    [10]Pharmacokinetics and Relative Bioavailability of Cyclosporin Pearls in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 1996, (6): 20-22.
  • Cited by

    Periodical cited type(4)

    1. 刘海帆,崔洁,王文全. 甘草地上部分黄酮类成分的代谢物及药代动力学参数研究概述. 天津中医药大学学报. 2022(01): 90-101 .
    2. 卞莹莹,邹纯才,鄢海燕,孙德考,胡倩. LC-MS/MS法研究瓜蒌缓释微丸在大鼠体内的药代动力学特征. 南方医科大学学报. 2020(07): 995-1000 .
    3. 潘诗苑,邹巧根,韩茉,高倩倩. UPLC-MS/MS测定人血浆中咪达那新的浓度及其生物等效性研究. 中国药科大学学报. 2019(05): 579-584 . 本站查看
    4. 刘博文,刘富垒,王如意,薛经纬,柳文媛,冯锋,曲玮. 苦木总生物碱的化学成分分析及其对大鼠胶原诱导性关节炎的作用. 中国药科大学学报. 2019(05): 585-592 . 本站查看

    Other cited types(3)

Catalog

    Article views (1148) PDF downloads (864) Cited by(7)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return